What is the financial value and structure of the takeover deal between Tate & Lyle and Ingredion?

Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) takeover offer from U.S. rival Ingredion, under which Tate & Lyle shareholders will receive 595 pence per share in cash — a premium of nearly 59% to its last closing price before talks were disclosed.

Why is this acquisition happening now, and what broader industry trend does it reflect?

The deal comes at a time when food companies are benefiting from consumers seeking more flavour amid a surge in weight-loss drug use.

Tate & Lyle Agrees to $3.6 Billion Takeover by Ingredion

Jun 7, 2026

UK-based Tate & Lyle has agreed to a $3.6 billion takeover by U.S. competitor Ingredion, creating a major food and beverage ingredients company. Shareholders will receive 595 pence per share, marking a nearly 59% premium over previous closing prices.

reuters

2026-02-26

Univar, Ingredion sign pharmaceutical distribution deal for US, Canada

2026-03-11

Univar, SI Group Expand EMEA Distribution Partnership for Performance Additives

2026-04-14

Unilever Bets Big on Gummies as Next Frontier in Wellness

2026-04-27

Hungary's MOL Says Talks on NIS Acquisition Ongoing

2026-05-14

Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid